logo

biotechnology & drugs News

Share

Biogen : CHMP Recommends VUMERITY For Approval In EU As Treatment For RRMS

Corcept Presents Positive Results From Phase 2 Trial Of Relacorilant On Ovarian Cancer

Merck Gets Positive EU CHMP Opinion For KEYTRUDA In Combination With Chemotherapy

Novartis Reports Findings From Real-world Study Evaluating Safety And Efficacy Of Alpelisib

Roche Gets Positive CHMP Opinion For Gavreto For Adults With RET Fusion-positive Advanced NSCLC

Grifols Agrees To Acquire Tiancheng (Germany) Pharmaceutical Holdings For EUR 1.1 Bln